Clinical trials
Placebo - Control clinical trials
Below are recruiting placebo - control clinical trials, each written for real people, not researchers. We’re tracking 3,905 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07311395Recruiting
Gentamicin injection to prevent infection after planned C-section
This study tests whether a local injection of gentamicin, an antibiotic, into the incision area can help prevent infections after a planned C-section. It may offer extra protection beyond standard antibiotics.
NahariyaAges 18 years+ - NCT07306754RecruitingPhase 1
A Safety Study of ABBV-243 in Healthy Adults
This study tests a new drug called ABBV-243 in healthy adults to see if it is safe and how the body processes it. Participation helps researchers understand the drug before studying it in people with a disease.
Grayslake, IllinoisAges 18–60 - NCT07314541RecruitingPhase 1
KMY Tablets Safety Study in Healthy Adults
This early-phase trial tests the safety of KMY tablets in healthy adults. It helps determine how well the drug is tolerated and how it moves through the body.
Suzhou, JiangsuAges 18–45 - NCT07311369RecruitingPhase 2
Testing a new pain tablet after abdominal surgery
This trial tests a new pain tablet (HL-1186) for people having abdominal surgery. It aims to see if the tablet is safe and works well to manage pain after the operation.
Changsha, HunanAges 18–75 - NCT07315516RecruitingPhase 2
Sleep and stress supplement study
This study tests a new supplement to help with sleep and stress. It is for adults who feel stressed and have sleep problems, but are otherwise healthy.
BrisbaneAges 18 years+ - NCT07311200RecruitingPhase 2
Study of D-2570 for active lupus
This trial tests a new oral medication called D-2570 for people with active systemic lupus erythematosus (SLE). It aims to see if the drug can help control lupus symptoms while you continue your current stable treatments.
Linfen, JiangxiAges 18–70 - NCT07309055RecruitingPhase 3
Study of SHR-1819 injection for teens with severe eczema
This trial tests an injectable medicine called SHR-1819 for teenagers aged 12 to 17 with severe atopic dermatitis (eczema) that has not responded well to creams or other treatments. The goal is to see if it can improve skin symptoms and reduce itching.
Shenyang, LiaoningAges 12–17 - NCT07311564RecruitingPhase 2
Study of LAD603 for adults with severe alopecia areata
This trial tests a new medication called LAD603 for people with severe to very severe alopecia areata, a condition causing significant hair loss. It aims to see if the drug can help regrow hair.
Omaha, NebraskaAges 18–65 - NCT07315061RecruitingPhase 2
Testing D-2570 for active psoriatic arthritis
This trial tests an oral medication, D-2570, for people with active psoriatic arthritis. It aims to see if the drug can reduce joint pain and swelling.
Chengdu, SichuanAges 18–70 - NCT07310264RecruitingPhase 1
Safety study of a new drug for Parkinson's disease
This trial tests a new drug called VT-5006 to see if it is safe for people with Parkinson's disease. It focuses on those who have stomach or bowel issues, like constipation.
LeidenAges 18–80 - NCT07307417Recruiting
Breathing muscle training for obesity
This trial tests if training your breathing muscles can improve respiratory function in people with obesity. It aims to help those with a BMI of 30 or higher.
Wroclaw, Dolny ŚląskAges 30–60 - NCT07311512Recruiting
Gum treatment and mouthwash study for gum disease
This trial tests if a professional gum cleaning combined with a special mouthwash can improve gum health and blood vessel function. It may help people with early gum disease who haven't had recent gum treatment.
Portsmouth, HampshireAges 30–75 - NCT07312110RecruitingPhase 2
D-Serine for slowing Parkinson's disease progression
This study tests whether a supplement called D-serine can slow the progression of Parkinson's disease. It is for people diagnosed within the last 5 years who have mild to moderate symptoms and are not yet dependent on a wheelchair.
Arendal, AgderAges 40–80 - NCT07313722RecruitingPhase 1
Testing a new eye drop for safety in healthy volunteers
This trial tests whether a new eye drop called BT01001 is safe for healthy adults. You may join if you have good overall and eye health, and do not use contact lenses or have chronic eye problems.
ShanghaiAges 18–50 - NCT07314359Recruiting
Study of a biofield patch on antioxidants and energy
This study tests a special patch (called a biofield patch) to see if it can improve your body's antioxidant levels and energy. It involves several clinic visits with blood draws over a short time period.
Klamath Falls, OregonAges 18–75 - NCT07313020Enrolling by invitationEarly Phase 1
Handheld imaging to track stem cells in knee osteoarthritis
This trial tests a new handheld imaging device (MPI) to track stem cells injected into the knee. It aims to see if the device can safely monitor how the stem cells move and work in people with knee osteoarthritis.
Haikou, HainanAges 18–75 - NCT07314411Recruiting
Carotenoids for Eye Health in Healthy Adults
This study tests if taking a carotenoid supplement (MacuHealth) can improve or protect retinal health in healthy adults. You might join if you have normal vision and no major eye or health problems.
Forest Grove, OregonAges 18–75 - NCT07310485Enrolling by invitation
Soy supplements for premenstrual syndrome in women approaching menopause
This study tests whether taking phytoestrogens (plant-based compounds that act like estrogen) can reduce premenstrual syndrome symptoms and affect gene expression in healthy women in their 40s and 50s. It may help women who are still having regular periods but are approaching menopause.
Amman, Amman GovernorateAges 40–55 - NCT07309315Recruiting
Testing a bacteria pill to prevent diarrhea from chemotherapy
This trial tests if a pill made from a harmless bacteria can prevent diarrhea caused by certain chemotherapy treatments. It is for people with advanced colorectal cancer or breast cancer who are about to start specific treatments.
Shenzhen, GuangdongAges 18 years+ - NCT07309471Recruiting
How DDH-LSD compares to LSD in the body
This study compares a substance called DDH-LSD to LSD to understand how the body processes it. It may help people who are curious about the effects of these substances in a controlled research setting.
BaselAges 18–65 - NCT04666714RecruitingPhase 3
Tested a new medicine to reduce diabetic nerve pain
This Phase 3 study tests Praga formulation to see if it safely reduces nerve pain caused by diabetes. You may qualify if you’re an adult with painful diabetic neuropathy and have certain symptom and pain scores on questionnaires.
Campinas, São PauloAges 18 years+ - NCT07298395RecruitingPhase 2
Study of ENV-294 for moderate-to-severe eczema
This trial tests an experimental cream or pill called ENV-294 in adults whose eczema is moderate to severe and hasn't gotten better with standard creams. It aims to see if ENV-294 can help control symptoms like itching and skin redness.
Birmingham, AlabamaAges 18–75 - NCT07305987RecruitingPhase 3
Eye drop study for people after cataract surgery
This study tests a new anti-inflammatory eye drop (PRO-232) in people who had routine cataract surgery on one eye the day before. The goal is to see if it helps control swelling and pain without problems.
Tijuana, Estado de Baja CaliforniaAges 18 years+ - NCT07299019RecruitingPhase 3
Study of orelabrutinib for secondary progressive MS
This study tests an oral medication called orelabrutinib for people whose multiple sclerosis has changed from relapsing-remitting to secondary progressive. The goal is to see if it can slow down disability worsening that happens even without relapses.
Phoenix, ArizonaAges 18–60
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo - control?
- Yes. Clin2 currently lists 3,905 recruiting placebo - control studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo - control trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo - control trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.